Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukemia in people at high risk ...

Anthony S. Stein, MD, discusses a study of total marrow and lymphoid irradiation 20 Gy and post-transplant cyclophosphamide in acute myeloid leukemia undergoing allogeneic hematopoietic cell ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

Family and friends of Rachel Simon of Hazlet are staging events to find a bone marrow donor who can help her fight off ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains ...

A study from the University of Cambridge has found that metformin, an inexpensive treatment for type 2 diabetes, could potentially prevent a form of acute myeloid leukaemia (AML) while studying ...

Aug. 21, 2024 — An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the synthesis of proteins that ...

A study from the University of Cambridge has found that metformin, an inexpensive treatment for type 2 diabetes, could potentially prevent a form of acute myeloid leukaemia (AML) while studying the ...

Exicure to initiate new clinical trial in acute myeloid leukaemia with GPC-100: Redwood City, California Tuesday, April 15, 2025, 18:00 Hrs [IST] Exicure, Inc., an early-stage bio ...

Alice Bolton, 28, who splits her time between Surrey and London, was diagnosed with acute myeloid leukaemia (AML), a severe form of blood cancer, in May 2024. Just days before her diagnosis ...

Article continues below Alice Bolton, a 28-year-old doctor was diagnosed with acute myeloid leukaemia (AML), an aggressive form of blood cancer, in May 2024 while working in A&E in Australia.